Dare Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
1.19
-0.04 (-3.25%)
At close: Jul 1, 2022 4:00 PM
1.18
-0.01 (-0.84%)
After-hours:
Jul 1, 2022 7:09 PM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization
|
101 | 153 | 51 | 14 | 8 | 13 | 19 | 77 | 125 |
| Market Cap Growth
|
- | 200.95% | 272.11% | 68.57% | -37.98% | -32.65% | -74.63% | -38.83% | - |
| Enterprise Value
|
63 | 102 | 47 | 10 | 1 | 6 | 20 | 21 | 77 |
| PE Ratio
|
- | -3.96 | -1.86 | -0.91 | -0.48 | -1.14 | -28.88 | -1.93 | -5.36 |
| PS Ratio
|
- | - | - | - | - | - | - | - | 1.00 |
| PB Ratio
|
3.26 | 3.95 | -44.20 | 31.03 | 1.21 | 0.98 | -27.34 | 1.57 | 2.76 |
| EV/Sales Ratio
|
- | - | - | - | - | - | - | - | 891.57 |
| Debt / Equity Ratio
|
0.04 | 0.01 | -0.66 | 1.82 | 0.00 | 0 | -0.98 | 0.42 | 0.07 |
| Debt / EBITDA Ratio
|
-0.03 | -0.01 | -0.03 | -0.06 | 0.00 | 0 | -1.11 | -0.55 | -0.14 |
| Debt / FCF Ratio
|
-0.04 | -0.01 | -0.03 | -0.06 | 0.00 | 0 | -1.87 | -0.63 | -0.16 |
| Current Ratio
|
2.92 | 3.45 | 0.91 | 1.15 | 6.64 | 8.64 | 0.06 | 4.73 | 6.56 |
| Asset Turnover
|
- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 |
| Return on Equity (ROE)
|
-145.60% | -189.60% | -11098.30% | -541.80% | -151.00% | -96.80% | -3.50% | -73.30% | -159.30% |
| Return on Assets (ROA)
|
-94.30% | -119.10% | -322.50% | -255.10% | -137.40% | -74.70% | -1.80% | -51.80% | -48.90% |
| Return on Capital (ROIC)
|
- | 586.60% | 1139.80% | 2341.80% | 100.00% | 1265.60% | -22.50% | -434.60% | 14765.50% |
| Earnings Yield
|
-39.45% | -25.26% | -53.84% | -110.04% | -206.26% | -87.90% | -3.46% | -51.71% | -18.65% |
| FCF Yield
|
-32.49% | -18.79% | -49.61% | -97.33% | -126.68% | -19.41% | -1.92% | -42.01% | -15.38% |
| Buyback Yield / Dilution
|
-88.63% | -103.23% | -93.16% | -45.16% | -232.04% | -287.10% | 67.17% | -74.80% | -2025.95% |
| Total Shareholder Return
|
-88.63% | -103.23% | -93.16% | -45.16% | -232.04% | -287.10% | 67.17% | -74.80% | -2025.95% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).